Jill Fallows Macaluso Esq., RN, has been Corporate Vice President and Chief Compliance Officer for Novo Nordisk Inc. since January 2018 and has been leading the US Compliance Program since being appointed Vice President and Chief Compliance Officer in September 2015. Jill is responsible for safeguarding corporate governance and integrity practices in the United States while upholding the company's commitment to operate according to the highest ethical standards of business conduct as part of the Novo Nordisk Way. She is also the Executive Sponsor for the EMERGE Employee Resource Group for Millennials, which aims to leverage the energy and influence of early career professionals to drive Novo Nordisk's purpose to defeat diabetes and other serious chronic conditions.

With 15 years of industry experience, Jill has been instrumental in evolving Novo Nordisk's compliance program to support industry leading business practices. By serving as a corporate compliance partner, she has spearheaded efforts focused on rebranding and operational efficiency. As chair of the Executive Ethics & Compliance Committee, she plays an active role ensuring compliance is incorporated into company decision-making processes.

Jill joined Novo Nordisk in 2003 and held several positions of escalating responsibility with in the Legal Team for nine years including Senior Corporate Counsel. She transitioned to the Compliance Department as Senior Director in 2012.

Previously, Jill was with the General Corporate and Healthcare practice of Day Pitney, LLP. She holds a Bachelor of Science in Nursing from the University of Pennsylvania and a Juris Doctorate from Rutgers University School of Law.